ABCC7 p.Arg792Gly

ClinVar: c.2374C>G , p.Arg792Gly D , Likely pathogenic
c.2374C>T , p.Arg792* ? , not provided
CF databases: c.2374C>T , p.Arg792* D , CF-causing
c.2374C>G , p.Arg792Gly (CFTR1) D , R792P was detected by SSCP and heteroduplex analysis followed by direct sequencing.
Predicted by SNAP2: A: D (85%), C: D (85%), D: D (95%), E: D (91%), F: D (85%), G: D (75%), H: D (85%), I: D (80%), K: D (71%), L: D (80%), M: D (85%), N: D (91%), P: D (95%), Q: D (80%), S: D (85%), T: D (85%), V: D (80%), W: D (91%), Y: D (80%),
Predicted by PROVEAN: A: D, C: D, D: D, E: N, F: D, G: D, H: N, I: D, K: N, L: D, M: D, N: N, P: D, Q: N, S: N, T: D, V: D, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Frelet A, Klein M
Insight in eukaryotic ABC transporter function by mutation analysis.
FEBS Lett. 2006 Feb 13;580(4):1064-84. Epub 2006 Jan 19., 2006-02-13 [PMID:16442101]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Ostedgaard LS, Baldursson O, Vermeer DW, Welsh MJ, Robertson AD
A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution.
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5657-62., 2000-05-09 [PMID:10792060]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Ravnik-Glavac M, Dean M, Glavac D
Two novel missense mutations (R766M and R792G) in exon 13 of the CFTR gene in a patient with congenital bilateral absence of the vas deferens.
Hum Hered. 2000 Sep-Oct;50(5):318-9., [PMID:10878476]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Rowntree RK, Harris A
The phenotypic consequences of CFTR mutations.
Ann Hum Genet. 2003 Sep;67(Pt 5):471-85., [PMID:12940920]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Dorfman R, Nalpathamkalam T, Taylor C, Gonska T, Keenan K, Yuan XW, Corey M, Tsui LC, Zielenski J, Durie P
Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?
Clin Genet. 2010 May;77(5):464-73. Epub 2009 Jan 6., [PMID:20059485]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Green DM, McDougal KE, Blackman SM, Sosnay PR, Henderson LB, Naughton KM, Collaco JM, Cutting GR
Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.
Respir Res. 2010 Oct 8;11:140., [PMID:20932301]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Vankeerberghen A, Wei L, Jaspers M, Cassiman JJ, Nilius B, Cuppens H
Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator.
Hum Mol Genet. 1998 Oct;7(11):1761-9., [PMID:9736778]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Chen JM, Scotet V, Ferec C
Definition of a "functional R domain" of the cystic fibrosis transmembrane conductance regulator.
Mol Genet Metab. 2000 Sep-Oct;71(1-2):245-9., [PMID:11001817]

Abstract [show]
Comments [show]
Sentences [show]